A5088122071- Management of metastatic bone disease
- Cancer survivorship and care
- Advanced Radiotherapy Techniques
- Cancer Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Venous Thromboembolism Diagnosis and Management
- Breast Cancer Treatment Studies
- Nausea and vomiting management
- Global Cancer Incidence and Screening
- Advances in Oncology and Radiotherapy
- Brain Metastases and Treatment
- Acute Myocardial Infarction Research
- Cancer Treatment and Pharmacology
- Spine and Intervertebral Disc Pathology
- Lung Cancer Research Studies
- Anesthesia and Pain Management
- Cardiac Valve Diseases and Treatments
- Aortic Disease and Treatment Approaches
- Economic and Financial Impacts of Cancer
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pain Management and Opioid Use
- Cancer-related cognitive impairment studies
- Head and Neck Cancer Studies
- Spinal Fractures and Fixation Techniques
- Effects of Radiation Exposure
McGill University
2025
Cégep de l'Outaouais
2025
St. George's University
2024
Health Sciences Centre
1991-2023
University of Auckland
2023
Sunnybrook Health Science Centre
2016-2023
Zero Emissions Resource Organisation
2022
Western University
2022
Advisory Board Company (United States)
2022
Warren Alpert Foundation
2021
Many studies that found improved quality of life (QOL) after radiotherapy bone metastases have small sample sizes and do not use specific questionnaires. How soon one can expect an improvement in QOL is unknown.To investigate at days 10 42 with a metastases-specific tool.In this secondary analysis the NCIC Clinical Trials Group Symptom Control Trial SC.23, double-blind randomized clinical trial investigated dexamethasone for prophylaxis pain flare radiotherapy, patients were accrued from 23...
The objectives of this study were to evaluate implant survival and success in the elderly population assess indicators risk factors for or failure dental implants older adults (aged 60 years older).This historical prospective was developed from a cohort patients born prior 1950 who received single private office. Implant marginal bone levels recorded analyzed with regard different patient- implant-related factors.The examined 245 patient charts 1,256 one clinic. mean age at time placement...
We argue that regional comparison of East Asian and European ethnic return migration policy offers important new perspectives on nationhood, nondiscrimination norms, trans-nationality. find despite international preferential is common in both regions. These policies at least implicitly define the nation as existing across borders. However, there are significant differences. states use co-ethnic preferences instrumentally for economic goals also offer treatment foreign investors. to coethnics...
The American Society of Clinical Oncology Quality Practice Initiative (QOPI) has provided a method for measuring process-based practice quality since 2006. We sought to determine whether QOPI scores showed improvement in measured over time and, if change was demonstrated, which factors either the measures or participants were associated with improvement.The analysis included 156 groups from larger group 308 that submitted data 2006 2010. One hundred fifty-two otherwise eligible practices...
Background: Whole brain radiotherapy (WBRT) is commonly used to treat metastases. Previous studies have explored how treatment time can affect response. The present study evaluated the influence of on overall survival (OS) for cancer patients receiving WBRT. Methods: Patients who received WBRT from 2004 2016 were included. Demographic information including age, performance status, primary site, dose, fraction, time, and date death collected. Based different percentages times falling into one...
Previous studies have observed how the time of radiotherapy delivery can impact toxicities and outcomes. The goal this study was to determine whether treatment influenced response for bone metastases.Patients who received radiation painful metastases from January 2000 December 2010 were included in our analysis. Demographic information including performance status, primary site, dose fraction, collected prospectively. Treatment times extracted patient medical records. Patients allocated 8:00...
1003 Background: Single-agent DOC is commonly used to treat MBC. Axitinib (AG) a potent TKI of VEGFRs. A phase I lead-in study identified 80 mg/m 2 q3wks in combination with 5 mg BID AG as the recommended dose. The primary objective was determine whether time progression (TTP) AG+DOC arm superior DOC+PL. Methods: Pts no prior chemotherapy for MBC and =12 mos from adjuvant (aCT), measurable disease, ECOG performance status (PS) 0–2, uncontrolled brain metastases were randomly assigned (2:1)...
BACKGROUND Patient travel distances, coupled with variation in facility‐level resources, create barriers for prostate cancer care the Veterans Health Administration integrated delivery system. For these reasons, authors investigated degree to which impact quality of care. METHODS The Affairs Central Cancer Registry was used identify all men who were diagnosed 2008. residence characterized using Rural Urban Commuting Area codes. then examined whether rural residence, compared urban associated...
Management of locally-advanced breast cancer is determined by multiple factors, but in patients without distant metastases often involves neoadjuvant systemic therapy, surgery and radiation. If the primary tumour remains unresectable following radiotherapy may be used for shrinkage prior to surgery. When metastatic disease present, locoregional generally reserved management tumour-related symptoms. We reviewed our experience high-dose unresected cancer.A retrospective chart review was...